Clinical Trials Browser

Phase NA × L-BLP25 × Clear all

NCT01423760 2016-10-06

Common Safety Follow-up Trial of Tecemotide (L-BLP25)

Phase NA Terminated

27 enrolled 7 charts

Plasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Multiple Myeloma